Verified peer comparison
Spero Therapeutics vs Canterbury Park Holding Financial Comparison
Direct answer
Spero Therapeutics and Canterbury Park Holding are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free Spero Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Spero Therapeutics Revenue
- 59,619,000 USD
- Canterbury Park Holding Revenue
- 59,567,585 USD
- Spero Therapeutics Operating income
- -24,000 USD
- Canterbury Park Holding Operating income
- 2,517,866 USD